Population-based differences in treatment outcome following anticancer drug therapies von Ma, Brigette BY, FRACP, Hui, Edwin P, MRCP, Mok, Tony SK, Prof

Volltext

Clinical efficacy of atezolizumab plus bevacizumab and chemotherapy in KRAS-mutated non-small cell lung cancer with STK11, KEAP1, or TP53 comutations: subgroup results from the pha... von West, Howard Jack, McCleland, Mark, Cappuzzo, Federico, Reck, Martin, Mok, Tony SK, Jotte, Robert M, Nishio, Makoto, Kim, Eugene, Morris, Stefanie, Zou, Wei, Shames, David, Das Thakur, Meghna, Shankar, Geetha, Socinski, Mark A

Volltext

Epigenetic inactivation of the CpG demethylase TET1 as a DNA methylation feedback loop in human cancers von Li, Lili, Li, Chen, Mao, Haitao, Du, Zhenfang, Chan, Wai Yee, Murray, Paul, Luo, Bing, Chan, Anthony TC, Mok, Tony SK, Chan, Francis KL, Ambinder, Richard F, Tao, Qian

Volltext

Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a r... von Reck, Martin, Mok, Tony S K, Nishio, Makoto, Jotte, Robert M, Cappuzzo, Federico, Orlandi, Francisco, Stroyakovskiy, Daniil, Nogami, Naoyuki, Rodríguez-Abreu, Delvys, Moro-Sibilot, Denis, Thomas, Christian A, Barlesi, Fabrice, Finley, Gene, Lee, Anthony, Coleman, Shelley, Deng, Yu, Kowanetz, Marcin, Shankar, Geetha, Lin, Wei, Socinski, Mark A, Reck, Martin, Mok, Tony SK, Nishio, Makoto, Jotte, Robert M, Cappuzzo, Federico, Orlandi, Francisco, Stroyakovskiy, Daniil, Nogami, Naoyuki, Rodríguez-Abreu, Delvys, Moro-Sibilot, Denis, Thomas, Christian A, Barlesi, Fabrice, Finley, Gene, Lee, Anthony, Coleman, Shelley, Deng, Yu, Kowanetz, Marcin, Shankar, Geetha, Lin, Wei, Socinski, Mark A

Volltext

Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant von To, Ka-Fai, Tong, Joanna HM, Yeung, King SF, Lung, Raymond WM, Law, Peggy PY, Chau, Shuk Ling, Kang, Wei, Tong, Carol YK, Chow, Chit, Chan, Anthony WH, Leung, Linda KS, Mok, Tony SK

Volltext

MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis von Tong, Joanna H, Yeung, Sai F, Chan, Anthony W H, Chung, Lau Y, Chau, Shuk L, Lung, Raymond Wai Ming, Tong, Carol Y, Chow, Chit, Tin, Edith K Y, Yu, Yau H, Li, Hui, Pan, Yi, Chak, Wing P, Ng, Calvin S H, Mok, Tony S K, To, Ka F

Volltext

Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin von Sun, Kun, Jiang, Peiyong, Cheng, Suk Hang, Cheng, Timothy H T, Wong, John, Wong, Vincent W S, Ng, Simon S M, Ma, Brigette B Y, Leung, Tak Y, Chan, Stephen L, Mok, Tony S K, Lai, Paul B S, Chan, Henry L Y, Sun, Hao, Chan, K C Allen, Chiu, Rossa W K, Lo, Y M Dennis

Volltext

363 KEYNOTE-042 5-year survival update: pembrolizumab versus chemotherapy in patients with previously untreated, PD-L1–positive, locally advanced or metastatic non–small-cell lung... von Castro, Gilberto de, Kudaba, Iveta, Wu, Yi-Long, Lopes, Gilberto, Kowalski, Dariusz M, Turna, Hande Z, Caglevic, Christian, Zhang, Li, Karaszewska, Boguslawa, Laktionov, Konstantin K, Srimuninnimit, Vichien, Bondarenko, Igor, Kubota, Kaoru, Mukherjee, Rinee, Lin, Jianxin, Souza, Fabricio, Mok, Tony SK, Cho, Byoung Chul

Volltext

Overcoming immunosuppression and pro-tumor inflammation in lung cancer with combined IL-1β and PD-1 inhibition von Lee, Jay M, Tsuboi, Masahiro, Kim, Edward S, Mok, Tony SK, Garrido, Pilar

Volltext

Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design von Garrido, Pilar, Pujol, Jean-Louis, Kim, Edward S, Lee, Jay M, Tsuboi, Masahiro, Gómez-Rueda, Ana, Benito, Amparo, Moreno, Nicolas, Gorospe, Luis, Dong, Tuochuan, Blin, Cecile, Rodrik-Outmezguine, Vanessa, Passos, Vanessa Q, Mok, Tony Sk

Volltext

364 KRAS mutations in patients with nonsquamous non–small-cell lung cancer: prevalence and relationship with PD-L1 expression, tumor mutation burden and smoking status von Garassino, Marina Chiara, Rodriguez-Abreu, Delvys, Gadgeel, Shirish M, Kowalski, Dariusz M, Kasahara, Kazuo, Felip, Enriqueta, Wu, Yi-Long, Castro, Gilberto de, Cho, Byoung Chul, Turna, Hande Z, Horinouchi, Hidehito, Reck, Martin, Hui, Rina, Garon, Edward B, Boyer, Michael, Mok, Tony SK, Lopes, Gilberto, Kobie, Julie, Li, Yongjin, Ayers, Mark A, Cristescu, Razvan, Zhao, Bin, Catherine Pietanza, M, Herbst, Roy S

Volltext

A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma von Chan, Stephen L., Cheng, Paul N.M., Liu, Angela M., Chan, Landon L., Li, Leung, Chu, Cheuk M., Chong, Charing C.N., Lau, Yat M., Yeo, Winnie, Ng, Kelvin K.C., Yu, Simon C.H., Mok, Tony S.K., Chan, Anthony W.H.

Volltext

Twenty‐five years of Respirology: Advances in lung cancer von Ang, Mei‐Kim, Mok, Tony S.K.

Volltext

A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma von Chan, Stephen L., Yeo, Winnie, Mo, Frankie, Chan, Anthony W.H., Koh, Jane, Li, Leung, Hui, Edwin P., Chong, Charing C.N., Lai, Paul B.S, Mok, Tony S.K., Yu, Simon C.H.

Volltext

Crizotinib in the management of advanced-stage non-small-cell lung cancer von Loong, Herbert H, Mok, Kevin, Leung, Linda KS, Mok, Tony SK

Volltext

Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1 von Li, Ming-Yue, Liu, Yi, Liu, Li-Zhong, Kong, Angel W. Y., Zhao, Zhili, Wu, Bin, Long, Xiang, Wu, Jun, Ng, Calvin S. H., Wan, Innes Y. P., Du, Jing, Mok, Tony S. K., Underwood, Malcolm J., Chen, George G.

Volltext

ARCHER 1050: first-line dacomitinib vs gefitinib for advanced NSCLC in patients with EGFR activating mutation(s) von Nakagawa, Kazuhiko, Mok, Tony SK, Wu, Yi-Long, Rosell, Rafael, Tsuji, Fumito, Wang, Tao, Sbar, Eric

Volltext

Correlation and prognostic significance of beta-galactoside alpha-2,6-sialyltransferase and serum monosialylated alpha-fetoprotein in hepatocellular carcinoma von Poon, Terence C W, Chiu, Clarissa H S, Lai, Paul B S, Mok, Tony S K, Zee, Benny, Chan, Anthony T C, Sung, Joseph J Y, Johnson, Philip J

Volltext

Clinical Outcomes with Erlotinib in Patients with Epidermal Growth Factor Receptor Mutation von Mok, Tony S. K., D’arcangelo, Manolo, Califano, Raffaele

Volltext

Genotype-Specific Genomic Markers Associated with Primary Hepatomas, Based on Complete Genomic Sequencing of Hepatitis B Virus von SUNG, Joseph J. Y, TSUI, Stephen K. W, LOCARNINI, Stephen, CHAN, Henry L. Y, TSE, Chi-Hang, NG, Eddie Y. T, LEUNG, Kwong-Sak, LEE, Kin-Hong, MOK, Tony S. K, BARTHOLOMEUSZ, Angeline, AU, Thomas C. C, TSOI, Kelvin K. F

Volltext